NIH-funded research R01 grant

Normobaric Oxygen Therapy to Protect Breathing After Spinal Cord Injury

Official title: Normobaric Oxygen Therapy for Spinal Cord Injury

Funded at University of Florida · NIH-11365957 · Data updated 2026-11-12

A study in people with cervical spinal cord injuries tests whether giving 100% oxygen at normal pressure right after injury can reduce inflammation and help preserve breathing.

More Spinal Cord Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 3, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$579,642
NIH project number5R01NS139422-03
Project IDNIH-11365957 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with acute cervical spinal cord injury who are eligible for oxygen therapy trials could participate.

Less likely to help

Patients with injuries outside the cervical region or those unable to tolerate high-concentration oxygen may not benefit.

What this research studies

Spinal cord injuries cut off blood flow and rapidly drop oxygen in the damaged area, leading to further damage. This project tests whether delivering oxygen at normal atmospheric pressure soon after injury can lessen inflammation driven by microglia and save breathing ability. Researchers will compare the effects of normobaric oxygen on spinal oxygen levels, inflammatory markers, and respiratory function in a cervical SCI model. The work builds on prior data suggesting benefits of high-oxygen therapy but aims to achieve similar effects without the complexity of hyperbaric treatment. If successful, this approach could provide a practical therapy to improve outcomes after cervical SCI.

Why it matters

Potential benefit: If successful, patients with cervical SCI could recover breathing and reduce long-term nerve damage through a simple oxygen therapy approach.

How similar studies have gone: Earlier hyperbaric oxygen studies showed anti-inflammatory effects, but this study seeks benefits with normobaric oxygen, which is less complex to administer.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Fuller, David D — University of Florida
  • Study coordinator: Fuller, David D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.